13F HOLDINGS REPORT
MWG Management Ltd.
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0000950123-23-002243
Total Value
$195.9M
Positions
3
Other Managers
1
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BEAM THERAPEUTICS INC | BEAM | 2,346,934 | $91.8M | 46.86% |
| 2 | LYELL IMMUNOPHARMA INC | LYEL | 20,162,332 | $70.0M | 35.72% |
| 3 | PRIME MEDICINE INC | PRME | 1,835,876 | $34.1M | 17.42% |